Skip to main content
. 2018 Mar 17;10:269–277. doi: 10.1016/j.dadm.2018.02.008

Fig. 1.

Fig. 1

Voxelwise gray matter and FDG-PET comparisons between amyloid-negative healthy controls (Aβneg HC) and amyloid-negative (Aβneg) and amyloid-positive (Aβpos) amnestic mild cognitive impairment (aMCI) patients. The threshold was set at P uncorrected < .001, k > 50 for MRI, and k > 120 for FDG-PET. Effect sizes are presented in Supplementary Fig. 1. Abbreviations: FDG, 18F-fluorodeoxyglucose; PET, positron emission tomography; MRI, magnetic resonance imaging.